medigraphic.com
Organo Oficial de la Sociedad Mexicana de Urología

2017, Número 5

<< Anterior Siguiente >>

Rev Mex Urol 2017; 77 (5)


Reflujo vesicoureteral sintomático posterior al injerto renal en adultos: tratamiento endourológico y reacción con agentes bloqueantes

Gutiérrez-Jiménez ÁA, Jiménez-López LA, Ricardez-Espinosa AA, George-Micceli E, Aguilar-Sandoval EG, Bravo-Duarte GA

Idioma: Español
Referencias bibliográficas: 33
Paginas: 419-424
Archivo PDF: 332.40 Kb.


RESUMEN

El reflujo vesicoureteral después del trasplante renal es una complicación común, que puede favorecer la aparición de infección de vías urinarias recurrente y cuadros de pielonefritis aguda en el injerto, lo que incrementa el riesgo de su pérdida. Por consenso general, los pacientes con reflujo vesicoureteral sintomático deben recibir tratamiento. El tratamiento endourológico ha demostrado curar el reflujo y disminuir el índice de infección de vías urinarias y pielonefritis con pocas complicaciones. En las últimas décadas se han prescrito diferentes fármacos e implementado diversas técnicas para el tratamiento del reflujo vesicoureteral sintomático posterior al trasplante renal. Este artículo revisa las diferentes técnicas utilizadas y analiza la eficacia de los distintos fármacos prescritos para el reflujo vesicoureteral sintomático posterior al trasplante renal en adultos.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Margreiter M, Györi GP, Böhmig GA, Trubel S, Mühlbacher F, Steininger R. Value of routine voiding cystourethrography after renal transplantation. Am J Transplant 2013;13(1):130-135.

  2. Jung GO, Chun JM, Park JB, Choi GS, Kwon CH, Joh JW, et al. Clinical significance of posttransplantation vesicoureteral reflux during short-term period after kidney transplantation. Transplant Proc 2008;40(7):2339-2341.

  3. Mastrosimone S, Pignata G, Maresca MC, Calconi G, Rabassini A, Butini R, et al. Clinical significance of vesicoureteral reflux after kidney transplantation. Clin Nephrol 1993;40:38-45.

  4. Duty BD, Conlin MJ, Fuchs EF, Barry JM. The current role of endourologic management of renal transplantation complications. Adv Urol 2013;2013:246520.

  5. Nie ZL, Zhang KQ, Li QS, Jin FS, Zhu FQ, Huo WQ. Urological complications in 1,223 kidney transplantations. Urol Int 2009;83(3):337-341.

  6. Al-Shaer MB, Al-Midani A. The management of urological complications in renal transplant patients. Saudi J Kidney Dis Transplant 2005;16(2):176-180.

  7. Dinckan A, Tekin A, Turkyilmaz S, Kocak H, Gurkan A, Erdogan O, et al. Early and late urological complications corrected surgically following renal transplantation. Transpl Int 2007;20(8):702-707.

  8. Martínez-Mier G, Jiménez-López LA, Valencia-Mercado D, George-Micelli E, Salas-Díaz FA, González-Medina MF. Urological complications following kidney transplantation using Lich-Gregoir technique: A 4-year experience in Mexico. Cir Cir 2009;77(2):111-114.

  9. Lebowitz RL, Olbing H, Parkkulainen KV, Smellie JM, Tamminen-Möbius TE. International system of radiographic grading of vesicoureteric reflux. International Reflux Study in Children. Pediatr Radiol 1985;15(2):105-109.

  10. Masahiko H, Kazunari T, Tokumoto T, Ishikawa N, Yagisawa T, Toma H. Comparative study of urosurgical complications in renal transplantation: intravesical versus extravesical ureterocystoneostomy. Transplant Proc 2000;32(7):1844-1846.

  11. Nie Z, Zhang K, Huo W, Li Q, Zhu F, Jin F. Comparison of urological complications with primary ureteroureterostomy versus conventional ureteroneocystostomy. Clin Transplant 2010;24(5):615-619.

  12. Secin FP, Rovegno AR, Marrugat RE, Virasoro R, Lautersztein GA, Fernandez H. Comparing Taguchi and Lich-Gregoir ureterovesical reimplantation techniques for kidney transplants. J Urol 2002;168(3):926-930.

  13. Farr A, Györi G, Mühlbacher F, Husslein P, Böhmig GA, Margreiter M. Gender has no influence on VUR rates after renal transplantation. Transpl Int 2014;27(11):1152-1158.

  14. Abbott KC, Swanson SJ, Richter ER, Bohen EM, Agodoa LY, Peters TG, et al. Late urinary tract infection after renal transplantation in the United States. Am J Kidney Dis 2004;44(2):353-362.

  15. Dupont PJ, Psimenou E, Lord R, Buscombe JR, Hilson AJ, Sweny P. Late recurrent urinary tract infections may produce renal allograft scarring even in the absence of symptoms or vesicoureteric reflux. Transplantation 2007;84(3):351-355.

  16. Pellé G, Vimont S, Levy PP, Hertig A, Ouali N, Chassin C, Arlet G, et al. Acute pyelonephritis represents a risk factor impairing long-term kidney graft function. Am J Transplant 2007;7(4):899-907.

  17. Karam G, Kälble T, Alcaraz A, Aki FT, Budde K, Humke U, et al.Guidelines on renal transplantation; European Association of Urology; 2014. [En línea]. Dirección URL: . [Consulta: 21 de mazo 2016].

  18. Matouschek E. Treatment of vesicorenal reflux by transurethral teflón-injection. Urologe A 1981;20(5):263-264.

  19. Hayn MH, Smaldone MC, Ost MC, Docimo SG. Minimally invasive treatment of vesicoureteral reflux. Urol Clin North Am 2008;35(3):477-488.

  20. Kirsch AJ, Perez-Brayfield M, Smith EA, Scherz HC. The modified sting procedure to correct vesicoureteral reflux: improved results with submucosal implantation within the intramural ureter. J Urol 2004;171:c2413-2416.

  21. McMann LP, Scherz HC, Kirsch AJ. Long-term preservation of dextranomer/hyaluronic acid copolymer implants after endoscopic treatment of vesicoureteral reflux in children: a sonographic volumetric analysis. J Urol 2007;177(1):316- 320.

  22. Yucel S, Akin Y, Celik O, Erdogru T, Baykara M. Endoscopic vesicoureteral reflux correction in transplanted kidneys: does injection technique matter?. J Endourol 2010;24(10):1661-1664.

  23. Pichler R, Buttazzoni A, Rehder P, Bartsch G, Steiner H, Oswald J. Endoscopic application of dextranomer/ hyaluronic acid copolymer in the treatment of vesicoureteric reflux after renal transplantation. BJU Int 2011;107(12):1967-1972.

  24. Romero NP, Romo MI, Vegas AG, Izquierdo JB, Varela JC, Arteche AH, et al. Deflux injections for vesicoureteral reflux in transplanted kidneys. Transplant Proc 2010;42(8):2892- 2895.

  25. Seifert HH, Mazzola B, Ruszat R, Muller A, Steiger J, Bachmann A, et al. Transurethral injection therapy with dextranomer/ hyaluronic acid copolymer (Deflux) for treatment of secondary vesicoureteral reflux after renal transplantation. J Endourol 2007;21(11):1357-1360.

  26. Cloix P, Gelet A, Desmettre O, Cochat P, Garnier JL, Dubernard JM, et al. Endoscopic treatment of vesicoureteric reflux in transplanted kidneys. Br J Urol 1993;72(1):20-22.

  27. Mallet R, Game X, Mouzin M, Sarramon JP, Vaessen C, Malavaud B, et al. Symptomatic vesicoureteral reflux in kidney transplantation: results of endoscopic injections of teflon and predictive factors for success. Prog Urol 2003;13(4):598-601.

  28. Antonopoulos IM, Piovesan AC, Falci R Jr, Kanashiro H, Saito FJ, Nahas WC. Transurethral injection therapy with carbon-coated beads (Durasphere®) for treatment of recurrent pyelonephritis in kidney transplant patients with vesico-ureteral reflux to the allograft. Clin Transplant 2011;25(2):329-333.

  29. Song JC, Hwang HS, Yoon HE, Kim JC, Choi BS, Kim YS, et al. Endoscopic subureteral polydimethylsiloxane injection and prevention of recurrent acute graft pyelonephritis. Nephron Clin Pract 2011;117(4):c385-c3869.

  30. Akiki A, Boissier R, Delaporte V, Maurin C, Gaillet S, Karsenty G, et al. Endoscopic treatment of symptomatic vesicoureteral reflux after renal transplantation. J Urol 2015;193(1):225-229.

  31. Latchamsetty KC, Mital D, Jensik S, Coogan CL. Use of collagen injections for vesicoureteral reflux in transplanted kidneys. Transplant Proc 2003;35(4):1378-1380.

  32. Nison L, Hazzan M, Puech P, Bouye S. Endoscopic polydimethylsiloxane injection in prevention of recurrent graft pyelonephritis for transplanted kidney with vesicoureteral reflux. Am J Transplant, 2016;16(Suppl 3). Dirección URL: . [Consulta: 13 de septiembre 2016].

  33. Aaronson IA, Rames RA, Greene WB, Walsh LG, Hasal UA, Garen PD. Endoscopic treatment of reflux: migration of Teflon to the lungs and brain. Eur Urol 1993;23(3):394-399.




2020     |     www.medigraphic.com